SEOM clinical guideline on unknown primary cancer (2017)
2017 · Clinical & Translational Oncology · 71 citations
https://doi.org/10.1007/s12094-017-1807-y
A
Anna Estival
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
911
Citations
15
h-index
22
i10-index
Anna Estival is an academic researcher from Universidad de Las Palmas de Gran Canaria. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Brain Metastases and Treatment. The author has an h-index of 15, co-authored 80 publications.
ORCID: 0000-0002-2788-9159Papers by this author
worksA Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors
2020 · The Oncologist · 18 citations
https://doi.org/10.1002/onco.13516
Immunogenicity of COVID-19 vaccines in lung cancer patients
2023 · Lung Cancer · 9 citations
https://doi.org/10.1016/j.lungcan.2023.107323
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry
2024 · Archivos de Bronconeumología · 5 citations
https://doi.org/10.1016/j.arbres.2024.07.006
Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer
2025 · ESMO Real World Data and Digital Oncology · 0 citations
https://doi.org/10.1016/j.esmorw.2025.100125
PCR227 The Economic Burden of Amyotrophic Lateral Sclerosis: An Observational Study of Out-of-Pocket Expenses and the Impact on Caregivers
2025 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2025.09.2700
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat